论文信息 - Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status. - 字舞流文

Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status.

Toshiaki Takahashi | H. Akamatsu | H. Daga | K. Nakashima | T. Taira | Y. Miyashita | H. Imai | K. Nishino | R. Ko | M. Kimura | Y. Hisamatsu | Takeya Sugimoto | T. Sugimoto